Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

What is next, and who is running it?

The next dated milestone on each program. A hollow marker is a registry primary completion date, not a company readout.

Phase 1 on
ClassNone selected
MechanismNone selected

Phase 1 included.

Clear filters

94 of 94 programs on this timeline

202520262027202820292030Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Today

Abbott 1

No dated milestone in 2025 to 2030

AbbVie 2

ABBV-295Phase 2
No dated milestone in 2025 to 2030
GUB014295Phase 1
No dated milestone in 2025 to 2030

Aconcagua Bio, Inc 1

ACCG-2671Phase 1/2
No dated milestone in 2025 to 2030

Alizyme 1

CetilistatPhase 1
No dated milestone in 2025 to 2030

Altimmune 1

No dated milestone in 2025 to 2030

Amgen 1

Registry, Jan 21, 2027

Arrowhead 1

ARO-ALK7Phase 1/2
Registry, Feb 2027

Ascletis Pharma (China) Co 1

ASC30Phase 3
No dated milestone in 2025 to 2030

AstraZeneca 5

CotadutidePhase 1
No dated milestone in 2025 to 2030
Registry, Nov 18, 2026
ExenatidePhase 3
No dated milestone in 2025 to 2030
PramlintidePhase 2/3
No dated milestone in 2025 to 2030
AZD6234Phase 3
Registry, May 4, 2027

Biohaven Therapeutics 1

No dated milestone in 2025 to 2030

Boehringer Ingelheim 1

Registry, Dec 8, 2026

BrightGene Bio-Medical Technology Co 1

BGM0504Phase 3
Registry, Feb 28, 2027

Carmot Australia First Pty Ltd 1

CT-996Phase 1
No dated milestone in 2025 to 2030

Carmot Therapeutics, Inc 1

CT-868Phase 2
No dated milestone in 2025 to 2030

Company n/r 3

BeinaglutideStage n/r
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
LoxenatidePhase 2/3
No dated milestone in 2025 to 2030

Corbus Pharmaceuticals 1

CRB-913Phase 1
No dated milestone in 2025 to 2030

CSPC Baike (Shandong) Biopharmaceutical Co 1

TG103Phase 3
No dated milestone in 2025 to 2030

Eli Lilly 8

TirzepatideApproved
Registry, Jan 2027
OrforglipronApproved
Registry, Sep 6, 2027
Registry, Mar 14, 2027
Registry, Mar 2028
No dated milestone in 2025 to 2030
LY4086940Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
BimagrumabPhase 2
Registry, Dec 31, 2028

Empros Pharma AB 1

OrlistatApproved
No dated milestone in 2025 to 2030

Fujian Shengdi Pharmaceutical Co 1

RibupatidePhase 3
Registry, Oct 31, 2027

Gan & Lee Pharmaceuticals 1

Registry, Jun 30, 2027

Gasherbrum Bio, Inc 1

No dated milestone in 2025 to 2030

GSK 1

No dated milestone in 2025 to 2030

Guangdong Raynovent Biotech Co 1

RAY1225Phase 3
No dated milestone in 2025 to 2030

Hangzhou Sciwind Biosciences Co 1

Registry, Jan 5, 2027

Hanmi 1

HM15211Phase 1
No dated milestone in 2025 to 2030

Hengrui 1

No dated milestone in 2025 to 2030

Huadong Medicine 3

HDM1002Phase 3
No dated milestone in 2025 to 2030
HDM1702Phase 3
No dated milestone in 2025 to 2030
HDM1005Phase 3
Registry, Dec 2026

Innovent 1

MazdutidePhase 3
Registry, Dec 31, 2026

Inversago Pharma 1

No dated milestone in 2025 to 2030

Merck 1

No dated milestone in 2025 to 2030

MindRank AI Ltd 1

MDR-001Phase 3
No dated milestone in 2025 to 2030

NeuroBo Pharmaceuticals Inc 1

DA-1726Phase 1
Registry, Nov 9, 2026

NeuroSearch 1

No dated milestone in 2025 to 2030

Novo Nordisk 9

SemaglutideApproved
Registry, Sep 6, 2028
Registry, Mar 2027
Registry, Jun 12, 2028
LiraglutideApproved
No dated milestone in 2025 to 2030
Registry, Feb 22, 2028
Registry, Jan 26, 2027
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
LorcaserinPhase 1/2
No dated milestone in 2025 to 2030

Orexigen Therapeutics, Inc 1

Registry, Dec 31, 2030

PegBio Co 1

No dated milestone in 2025 to 2030

Pfizer 5

Registry, Sep 21, 2027
No dated milestone in 2025 to 2030
MET-233IPhase 1/2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Regeneron 3

HS-20094Phase 3
Registry, Nov 13, 2026
GaretosmabPhase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Rhythm 2

Registry, Mar 13, 2027
LB54640Phase 2
No dated milestone in 2025 to 2030

Roche 3

Registry, Oct 20, 2028
No dated milestone in 2025 to 2030
CT-388Phase 3
Registry, Nov 12, 2027

Sanofi 3

No dated milestone in 2025 to 2030
RimonabantPhase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Scholar Rock 1

No dated milestone in 2025 to 2030

Scohia 1

SCO-940/CT-G32Preclinical
No dated milestone in 2025 to 2030

Shandong Suncadia Medicine Co 1

No dated milestone in 2025 to 2030

Shanghai Yinnuo Pharmaceutical Technology Co 1

Registry, Nov 30, 2026

Shanghai Yinnuo Pharmaceutical Technology Co. 1

SupaglutidePhase 2/3
No dated milestone in 2025 to 2030

Shionogi 1

VelneperitPhase 2
No dated milestone in 2025 to 2030

Skye Bioscience 1

NimacimabPhase 2
Registry, Nov 20, 2026

Terns, Inc 1

TERN-601Phase 2
No dated milestone in 2025 to 2030

The United Bio-Technology (Hengqin) Co 1

UBT251Phase 3
Registry, Jan 14, 2027

Verdiva Bio Dev Limited 1

VRB-101Phase 2
No dated milestone in 2025 to 2030

Veru Inc 1

EnobosarmPhase 2
No dated milestone in 2025 to 2030

Viking Therapeutics 2

VK2735Phase 3
Registry, Jul 2027
No dated milestone in 2025 to 2030

Vincentage Pharma Co 1

VCT220Phase 3
No dated milestone in 2025 to 2030

VIVUS 1

No dated milestone in 2025 to 2030

Zafgen 1

BeloranibPhase 3
No dated milestone in 2025 to 2030

Zealand Pharma 1

No dated milestone in 2025 to 2030